KAITLIN KRAEMER: Open Payments
NPI 1548507445 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 30 payments from 15 companies in 2025. Trend: 2023 $654 · 2024 $1,000 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $181 |
| ABBVIE INC. | 4 | $106 |
| Amgen Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $63 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| PFIZER INC. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 1 | $35 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: BREZTRI, LINZESS, ELIQUIS, OTEZLA, TRELEGY ELLIPTA, GEMTESA, AIRSUPRA, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
